Viridian Therapeutics
VRDN
#4911
Rank
S$1.96 B
Marketcap
$24.83
Share price
6.27%
Change (1 day)
-8.25%
Change (1 year)

EPS for Viridian Therapeutics (VRDN)

EPS in 2023 (TTM): -$6.61

According to Viridian Therapeutics's latest financial reports the company's current EPS (TTM) is -$6.67. In 2022 the company made an earnings per share (EPS) of -$5.52 an increase over its 2021 EPS that were of -$10.38.

EPS history for Viridian Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.6119.7%
2022-$5.52-46.83%
2021-$10.38-73.94%
2020-$39.8444.73%
2019-$27.5322.94%
2018-$22.39-27.33%
2017-$30.81-91.47%
2016-$361.14-19.17%
2015-$446.79-75.48%
2014-$1,822582.47%
2013-$267.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.99-55.24%๐Ÿ‡บ๐Ÿ‡ธ USA